By Professor David Lawson Morris

Journal articles

Tudor E; Chua TC; Liauw WS; Morris DL, 2010, 'Risk factors and clinicopathological study of prognostic factors in the peritoneal mesothelioma.', American Surgeon, 76, pp. 400 - 405

Chua TC; Robertson G; Liauw WS; Morris DL, 2010, 'Salvage cytoreduction for chemorefractory ovarian cancer with peritoneal carcinomatosis: A last chance or futile efforts?', Australian and New Zealand Journal of Obstetrics and Gynaecology, 50, pp. 478 - 484, http://dx.doi.org/10.1111/j.1479-828X.2010.01201.x

Chua TC; Liauw WS; Robertson G; Morris DL, 2010, 'Second-line treatment of first relapse recurrent ovarian cancer', Australian and New Zealand Journal of Obstetrics and Gynaecology, 50, pp. 465 - 471, http://dx.doi.org/10.1111/j.1479-828X.2010.01209.x

Chua TC; Al-Zahrani A; Saxena A; Liauw WS; Zhao J; Morris DL, 2010, 'Secondary cytoreduction and perioperative intraperitoneal chemotherapy after initial debulking of pseudomyxoma peritonei: A study of timing and the impact of malignant dedifferentiation.', Journal of the American College of Surgeons, 211, pp. 526 - 535, http://dx.doi.org/10.1016/j.jamcollsurg.2010.06.011

Chua TC; Bester L; Akhter J; Morris DL, 2010, 'Successful right hepatectomy after four treatments of yttrium-90 microspheres (SIR-Spheres (R)) and concomitant FOLFOX as bridging therapy to resection of colorectal liver metastases.', Anticancer Research, 30, pp. 3005 - 3008

Chua TC; Saxena A; Morris DL, 2010, 'Surgical metastasectomy in AJCC stage IV M1c melanoma patients with gastrointestinal and liver metastases', Annals of Academy of Medicine Singapore, 39, pp. 634 - 639

evans KJ; Richardson M; Pavlakis N; Morris DL; Liauw WS; Bester L, 2010, 'Survival outcomes of a salvage patient population after radioembolization of hepatic metastases with yttrium-90 microspheres', Journal of Vascular and Interventional Radiology, 21, pp. 1521 - 1526, http://dx.doi.org/10.1016/j.jvir.2010.06.018

Chua TC; Liauw WS; Saxena A; Chu F; Glenn DW; Chai A; Morris DL, 2010, 'Systematic review of neoadjuvant transarterial chemoembolization for resectable hepatocellular carcinoma', Liver International, 30, pp. 166 - 174, http://dx.doi.org/10.1111/j.1478-3231.2009.02166.x

Chua TC; Saxena A; Liauw WS; Kokandi A; Morris DL, 2010, 'Systematic review of randomized and nonrandomized trials of the clinical response and outcomes of neoadjuvant systemic chemotherapy for resectable colorectal liver metastases', Annals of Surgical Oncology, 17, pp. 492 - 501, http://dx.doi.org/10.1245/s10434-009-0781-1

Pourgholami MH; Cai YZ; Chu SW; Galettis P; Morris DL, 2010, 'The influence of ovarian cancer induced peritoneal carcinomatosis on the pharmacokinetics of albendazole in nude mice.', Anticancer Research, 30, pp. 423 - 428

Morris DL; Chua TC, 2010, 'Treatments and outcomes of peritoneal surface tumors through a Centralized National Service (United Kingdom)', Diseases of the Colon and Rectum, 53, pp. 1218 - 1219, http://dx.doi.org/10.1007/DCR.0b013e318e28bcf

Saxena A; Bester L; Chua TC; Chu F; Morris DL, 2010, 'Yttrium-90 radiotherapy for unresectable intrahepatic cholangiocarcinoma: a preliminary assessment of this novel treatment option', Annals of Surgical Oncology, 17, pp. 484 - 491, http://dx.doi.org/10.1245/s10434-009-0777-x

Shehata M; Yan K; Itoh S; King J; Glenn D; Quinn R; Morris DL, 2009, 'Splenomegaly and tumor marker response following selective internal radiation therapy for non-resectable liver metastases from neuroendocrine tumor', Dokkyo Journal of Medical Sciences, 36, pp. 131 - 134

Patyna S; Haznedar J; Morris D; Freshwater K; Peng G; Sukbuntherng J; Chmielewski G; Matsumoto D, 2009, 'Evaluation of the safety and pharmacokinetics of the multi-targeted receptor tyrosine kinase inhibitor sunitinib during embryo-fetal development in rats and rabbits', Birth Defects Research Part B - Developmental and Reproductive Toxicology, 86, pp. 204 - 213, http://dx.doi.org/10.1002/bdrb.20194

Chua TC; Robertson G; Farrell R; Liauw W; Yan TD; Morris DL, 2009, 'Systematic review of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian peritoneal carcinomatosis: A more efficacious way of delivering intraperitoneal chemotherapy', Journal of Clinical Oncology, http://dx.doi.org/10.1200/jco.2009.27.15_suppl.5524

Chua TC; Yao P; Akther J; Bao S; Young L; Yan TD; Samaraweera U; Morris DL, 2009, 'Differential expression of Ki-67, estrogen receptor and progesterone receptor between genders in peritoneal mesothelioma', ANNALS OF SURGICAL ONCOLOGY, 16, pp. 32 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000207857400095&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cao C; Yan TD; Black DA; Morris DL, 2009, 'A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin', Annals of Surgical Oncology, 16, pp. 2152 - 2165, http://dx.doi.org/10.1245/s10434-009-0487-4

Cao C; Yan TD; Liauw WS; Morris DL, 2009, 'Comparison of optimally resected hepatectomy and peritonectomy patients with colorectal cancer metastasis', Journal of Surgical Oncology, 100, pp. 529 - 533, http://dx.doi.org/10.1002/jso.21369

Chua TC; Pelz J; Kerscher A; Morris DL; Esquivel J, 2009, 'Critical Analysis of 33 Patients with Peritoneal Carcinomatosis Secondary to Colorectal and Appendiceal Signet Ring Cell Carcinoma', Annals of Surgical Oncology, 16, pp. 2765 - 2770

Yan TD; Deraco M; Baratti D; Kusamura S; Elias D; Glehen O; Gilly F; Levine E; Shen P; Mohamed F; Moran B; Morris DL; Chua TC; Piso P; Sugarbaker PH, 2009, 'Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: Multi-institutional experience', Journal of Clinical Oncology, 27, pp. 6237 - 6242, http://dx.doi.org/10.1200/JCO.2009.23.9640

Chua TC; Koh J; Yan TD; Liauw WS; Morris DL, 2009, 'Cytoreductive surgey and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from small bowel adenocarcinoma', Journal of Surgical Oncology, 100, pp. 139 - 143, http://dx.doi.org/10.1002/jso.21315

Chua T; Yao P; Young L; Akhter J; Bao S; samaraweera U; Yan TD; Morris DL, 2009, 'Differential expression of Ki-67 and sex steroid hormone receptors between genders in peritoneal mesothelioma', Pathology and Oncology Research, 15, pp. 671 - 678, http://dx.doi.org/10.1007/s12253-009-9170-0

Chua TC; Liauw WS; Robertson G; Morris DL, 2009, 'Establishing evidence for change in ovarian cancer surgery - proposing clinical trials of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer peritoneal carcinomatosis', Gynecologic Oncology, 115, pp. 166 - 168, http://dx.doi.org/10.1016/j.ygyno.2009.06.010

Koh J; Yan TD; Glenn DW; Morris DL, 2009, 'Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis', Annals of Surgical Oncology, 16, pp. 327 - 333, http://dx.doi.org/10.1245/s10434-008-0234-2

Haghighi K; Glenn DW; Gruenberger T; Morris DL, 2009, 'Extending the limits for curative liver resections by portal vein embolisation', International Surgery, 94, pp. 43 - 47

Ding JH; Chua TC; Glenn DW; Morris DL, 2009, 'Feasibility of ablation as an alternative to surgical metastasectomy in patients with unresectable sarcoma pulmonary metastases', Interactive Cardiovascular and Thoracic Surgery, 9, pp. 1051 - 1053, http://dx.doi.org/10.1510/icvts.2009.218743

Chua TC; Akhter J; Yao P; Morris DL, 2009, 'In vivo model of pseudomyxoma peritonei for novel candidate drug discovery', Anticancer Research, 29, pp. 4051 - 4055

Pourgholami MH; Cai ZY; Wang L; Badar S; Links MJ; Morris DL, 2009, 'Inhibition of cell proliferation, vascular endothelial growth factor and tumor growth by albendazole', Cancer Investigation, 27, pp. 171 - 177, http://dx.doi.org/10.1080/07357900802210752

Chua TC; Robertson G; Liauw WS; Farrell R; Yan TD; Morris DL, 2009, 'Intraoperative hyperthermic intraperitoneal chemotherapy after cytoreductive surgery in ovarian cancer peritoneal carcinomatosis: systematic review of current results', Journal of Cancer Research and Clinical Oncology, 135, pp. 1637 - 1645, http://dx.doi.org/10.1007/s00432-009-0667-4

Chua TC; Yan TD; Smigielski ME; Zhu K; Ng K; Zhao J; Morris DL, 2009, 'Long-term survival in patients with pseudomyxoma peritonei treated with cytoreductive surgery and perioperative intraperitoneal chemotherapy: 10 years experience from a single institution', Annals of Surgical Oncology, 16, pp. 1903 - 1911, http://dx.doi.org/10.1245/s10434-009-0341-8

Chua TC; Liauw WS; Morris DL, 2009, 'New treatments and outcomes in peritoneal carcinomatosis', Medical Journal of Australia, 191, pp. 3 - 4

Chua TC; Yan TD; Morris DL, 2009, 'Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: The Australian Experience', Journal of Surgical Oncology, 99, pp. 109 - 113, http://dx.doi.org/10.1002/jso.21177

Chua TC; Yan TD; Zhao J; Morris DL, 2009, 'Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection', European Journal of Surgical Oncology, 35, pp. 1299 - 1305, http://dx.doi.org/10.1016/j.ejso.2009.07.005

Chua TC; Yan TD; Morris DL, 2009, 'Peritoneal mesothelioma: current understanding and management', Canadian Journal of Surgery, 52, pp. 59 - 64

Chu SW; Badar S; Morris DL; Pourgholami MH, 2009, 'Potent inhibition of tubulin polymerisation and proliferation of paclitaxel-resistant 1A9PTX22 human ovarian cancer cells by albendazole', Anticancer Research, 29, pp. 3791 - 3796

Zhu K; Morris DL, 2009, 'Primary peritonectomy / HIPEC for disseminated peritoneal adenomucinosis achieves much lower recurrence rates and better survival than secondary procedures', Surgeon - Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland, 7, pp. 345 - 350

Ng K; Yan TD; Black DA; Chu F; Morris DL, 2009, 'Prognostic determinants for survival after resection/ablation of a large hepatocellular carcinoma', HPB, 11, pp. 311 - 320, http://dx.doi.org/10.1111/j.1477-2574.2009.00044.x

Chua TC; Almohaimeed K; Liauw WS; Morris DL, 2009, 'Pseudomyxoma peritonei: A need to establish evidence-based standard of care - Is this the right trial?', Annals of Surgical Oncology, 16, pp. 2675 - 2677, http://dx.doi.org/10.1245/s10434-009-0550-1

Zhu JC; Yan TD; Glenn DW; Morris DL, 2009, 'Radiofrequency ablation of lung tumors: Feasibility and safety', Annals of Thoracic Surgery, 87, pp. 1023 - 1029, http://dx.doi.org/10.1016/j.athoracsur.2008.11.017

Adie S; Yip C; Chu F; Morris DL, 2009, 'Resection of liver metastases from colorectal cancer: does preoperative chemotherapy affect the accuracy of PET in preoperative planning?', Australian and New Zealand Journal of Surgery, 79, pp. 358 - 361, http://dx.doi.org/10.111/j.1445-2197.2009.04889.x

Saxena A; Yan TD; Chua TC; Fransi S; Almohaimeed K; Ahmed S; Morris DL, 2009, 'Risk factors for massive blood transfusion in cytoreductive surgery: A multivariate analysis of 243 procedures', Annals of Surgical Oncology, 16, pp. 2195 - 2203, http://dx.doi.org/10.1245/s10434-009-0484-7

Chua TC; Yan TD; Saxena A; Morris DL, 2009, 'Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality', Annals of Surgery, 249, pp. 900 - 907, http://dx.doi.org/10.1097/SLA.0b013e3181a45d86

Chua TC; Yan TD; Ng K; Zhao J; Morris DL, 2009, 'Significance of lymph node metastasis in patients with colorectal cancer peritoneal carcinomatosis', World Journal of Surgery, 33, pp. 1488 - 1494, http://dx.doi.org/10.1007/s00268-009-0059-6

Zhu JC; Yan TD; Morris DL, 2009, 'SO01
CYTOREDUCTIVE SURGERY AND INTRAPERITONEAL CHEMOTHERAPY FOR PERIOTONEAL CARCINOMATOSIS – 208 CONSECUTIVE PATIENTS', ANZ Journal of Surgery, 79, http://dx.doi.org/10.1111/j.1445-2197.2009.04932_1.x

Zhu JC; Yan TD; Morris DL, 2009, 'SO11P
CYTOREDUCTIVE SURGERY AND INTRAPERITONEAL CHEMOTHERAPY FOR PERIOTONEAL MESOTHEMLIOMA', ANZ Journal of Surgery, 79, http://dx.doi.org/10.1111/j.1445-2197.2009.04932_11.x

Chua TC; Yan TD; Morris DL, 2009, 'Surgical biology for the clinician: Peritoneal mesothelioma: current understanding and management', Canadian Journal of Surgery, 52, pp. 59 - 64

Chua TC; Liauw WS; Morris DL, 2009, 'The St George Hospital peritoneal surface malignancy program - where are we now?', Australian and New Zealand Journal of Surgery, 79, pp. 416 - 418, http://dx.doi.org/10.1111/j.1445-2197.2009.04940.x

Chua TC; Yan TD; Yap Z; Horton MD; Femanis GG; Morris DL, 2009, 'Thoracic cytoreductive surgery and intraoperative hyperthermic intrathoracic chemotherapy for pseudomyxoma peritonei', Journal of Surgical Oncology, 99, pp. 292 - 295, http://dx.doi.org/10.1002/jso.21230

Chua TC; Liauw WS; Robertson G; Chia WT; Soo K; AlObaid A; Almohaimeed K; Morris DL, 2009, 'Towards a randomized trials of cytoreductive surgery using peritonectomy and hyperthermic intraperitoneal chemotherapy for ovarian cancer peritoneal carcinomatosis', Gynecologic Oncology, 114, pp. 137 - 139, http://dx.doi.org/10.1016/j.ygyno.2009.03.002

Mekkawy AH; Morris DL; Pourgholami MH, 2009, 'Urokinase plasminogen activator system as a potential target for cancer therapy', Future Oncology, 5, pp. 1487 - 1499, http://dx.doi.org/10.2217/FON.09.108

Back to profile page